Follow
Felix Heymann
Felix Heymann
Senior researcher, Charité Berlin, Dept. of Hepatology and Gastroenterology, CVK
Verified email at charite.de
Title
Cited by
Cited by
Year
Immunology in the liver—from homeostasis to disease
F Heymann, F Tacke
Nature reviews Gastroenterology & hepatology 13 (2), 88-110, 2016
9662016
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
C Baeck, A Wehr, KR Karlmark, F Heymann, M Vucur, N Gassler, S Huss, ...
Gut 61 (3), 416-426, 2012
6212012
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
F Heymann, J Peusquens, I Ludwig‐Portugall, M Kohlhepp, C Ergen, ...
Hepatology 62 (1), 279-291, 2015
3702015
Role of IL-17 and Th17 cells in liver diseases
L Hammerich, F Heymann, F Tacke
Journal of Immunology Research 2011, 2011
3262011
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
JC Mossanen, O Krenkel, C Ergen, O Govaere, A Liepelt, T Puengel, ...
Hepatology 64 (5), 1667-1682, 2016
3132016
The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis
HJ Paust, JE Turner, OM Steinmetz, A Peters, F Heymann, C Ho, G Wolf, ...
Journal of the American Society of Nephrology 20 (5), 969-979, 2009
2992009
Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis
A Wehr, C Baeck, F Heymann, PM Niemietz, L Hammerich, C Martin, ...
The Journal of Immunology 190 (10), 5226-5236, 2013
2742013
Monocytes and macrophages as cellular targets in liver fibrosis
F Heymann, C Trautwein, F Tacke
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2009
2692009
Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ …
C Baeck, X Wei, M Bartneck, V Fech, F Heymann, N Gassler, K Hittatiya, ...
Hepatology 59 (3), 1060-1072, 2014
2652014
TAK1 suppresses a NEMO-dependent but NF-κB-independent pathway to liver cancer
K Bettermann, M Vucur, J Haybaeck, C Koppe, J Janssen, F Heymann, ...
Cancer cell 17 (5), 481-496, 2010
2582010
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury
F Heymann, C Meyer-Schwesinger, EE Hamilton-Williams, L Hammerich, ...
The Journal of clinical investigation 119 (5), 1286-1297, 2009
2482009
M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment
E Van Overmeire, B Stijlemans, F Heymann, J Keirsse, Y Morias, Y Elkrim, ...
Cancer research 76 (1), 35-42, 2016
2372016
The concanavalin A model of acute hepatitis in mice
F Heymann, K Hamesch, R Weiskirchen, F Tacke
Laboratory animals 49 (1_suppl), 12-20, 2015
2302015
Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis
L Hammerich, JM Bangen, O Govaere, HW Zimmermann, N Gassler, ...
Hepatology 59 (2), 630-642, 2014
1932014
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice
F Heymann, L Hammerich, D Storch, M Bartneck, S Huss, V Rüsseler, ...
Hepatology 55 (3), 898-909, 2012
1862012
Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
S Lefere, T Puengel, J Hundertmark, C Penners, AK Frank, A Guillot, ...
Journal of hepatology 73 (4), 757-770, 2020
1822020
Peptide-functionalized gold nanorods increase liver injury in hepatitis
M Bartneck, T Ritz, HA Keul, M Wambach, J Bornemann, U Gbureck, ...
Acs Nano 6 (10), 8767-8777, 2012
1642012
Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries
J Bábíčková, BM Klinkhammer, EM Buhl, S Djudjaj, M Hoss, F Heymann, ...
Kidney international 91 (1), 70-85, 2017
1562017
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice
U Panzer, OM Steinmetz, HJ Paust, C Meyer-Schwesinger, A Peters, ...
Journal of the American Society of Nephrology 18 (7), 2071-2084, 2007
1272007
CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis
KM Schneider, V Bieghs, F Heymann, W Hu, D Dreymueller, L Liao, ...
Hepatology 62 (5), 1405-1416, 2015
1102015
The system can't perform the operation now. Try again later.
Articles 1–20